Losurdo, G.; Lacavalla, I.; Russo, F.; Riezzo, G.; Brescia, I.V.; Rendina, M.; Ierardi, E.; Di Leo, A.
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. Antibiotics 2022, 11, 78.
https://doi.org/10.3390/antibiotics11010078
AMA Style
Losurdo G, Lacavalla I, Russo F, Riezzo G, Brescia IV, Rendina M, Ierardi E, Di Leo A.
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. Antibiotics. 2022; 11(1):78.
https://doi.org/10.3390/antibiotics11010078
Chicago/Turabian Style
Losurdo, Giuseppe, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Vita Brescia, Maria Rendina, Enzo Ierardi, and Alfredo Di Leo.
2022. "Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy" Antibiotics 11, no. 1: 78.
https://doi.org/10.3390/antibiotics11010078
APA Style
Losurdo, G., Lacavalla, I., Russo, F., Riezzo, G., Brescia, I. V., Rendina, M., Ierardi, E., & Di Leo, A.
(2022). Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy. Antibiotics, 11(1), 78.
https://doi.org/10.3390/antibiotics11010078